Skip to main content
. 2021 May;9(10):836. doi: 10.21037/atm-21-298

Table 2. Characteristics according to type of admission to the ICU in patients with lung cancer.

Characteristic Total ICU Surgical ICU Medical ICU P value
(N=23,365) (N=9,482) (N=13,883)
Female 6,586 (28.2%) 2,886 (30.4%) 3,700 (26.7%) <0.01
Age 66.5±10.9 63.6±10.1 68.5±11.0 <0.01
Type of received therapy
   Surgery only 4,410 (18.9%) 3,948 (41.6%) 462 (3.3%) <0.01
   Systemic therapy with surgery 6,343 (27.1%) 5,534 (58.4%) 809 (5.8%) <0.01
   Systemic therapy without surgery 7,127 (30.5%) 0 (0.0%) 7,127 (51.3%) <0.01
   No treatment 1,842 (7.9%) 0 (0.0%) 1,842 (13.3%) <0.01
   Refusal of any treatments 3,643 (15.6%) 0 (0.0%) 3,643 (26.2%) <0.01
Charlson Comorbidity Index 9.1±3.9 8.6±4.0 9.5±3.8 <0.01
Overall follow-up (days) 1,131.3±994.1 1,776.3±874.8 690.7±813.9 <0.01
Renal replacement Therapy 1,086 (4.6%) 280 (3.0%) 806 (5.8%) <0.01
Need for Mechanical ventilator 9,169 (39.2%) 2,535 (26.7%) 6,634 (47.8%) <0.01
Interval from diagnosis to ICU 242.9±461.9 53.1±197.3 372.5±539.5 <0.01
ICU mortality at 28-day 5,692 (24.4%) 141 (1.5%) 5,551 (40.0%) <0.01
ICU mortality at 60-day 7,901 (33.8%) 306 (3.2%) 7,595 (54.7%) <0.01
ICU mortality at 1-year 11,656 (49.9%) 1,078 (11.4%) 10,578 (76.2%) <0.01
ICU mortality at 2-year 13,322 (57.0%) 1,905 (20.1%) 11,417 (82.2%) <0.01
ICU mortality at 3-year 14,357 (61.4%) 2,579 (27.2%) 11,778 (84.8%) <0.01
Overall mortality 16,429 (70.3%) 4,226 (44.6%) 12,203 (87.9%) <0.01
Overall ICU mortality 6,868 (29.4%) 279 (2.9%) 6,589 (47.5%) <0.01
CPR at death 2,047 (87.8%) 474 (93.3%) 1,573 (86.3%) <0.01
ICU length of stay 34.2±143.9 25.1±123.3 40.4±156.2 <0.01
Survival after ICU discharge 328.5±547.4 908.7±676.2 127.5±296.9 <0.01

CPR, cardiopulmonary resuscitation.